Mapping axonal injury distribution in mild traumatic brain injury with quantitative proton MR spectroscopy
Ivan Kirov1,2, Matthew S. Davitz1,2, Assaf Tal3, James S. Babb1,2, Robert I Grossman1,2, Yvonne W Lui1,4, and Oded Gonen1,2

1Center for Advanced Imaging Innovation and Research (CAI2R), New York University School of Medicine, New York, NY, United States, 2Bernard and Irene Schwartz Center for Biomedical Imaging, New York University School of Medicine, New York, NY, United States, 3Chemical Physics, Weizmann Institute of Science, Rehovot, Israel, 4Bernard and Irene Schwartz Center for Biomedical Imaging, New York, NY, United States

Synopsis

Since axonal injury is a primary outcome of traumatic brain injury, our goal was to characterize its regional distribution from a metabolic perspective. We set out to identify regions prone to disproportionate injury, hence, candidate targets in potential clinical applications of proton MR spectroscopy (1H-MRS). We found that metabolic axonal injury is diffusely distributed among commonly injured tracts, but multivoxel 1H-MRS may lack sensitivity for its detection on a regional basis. These results motivate the use of 1H-MRS approaches with higher sensitivity, such as global averaging, or large "single voxels" in areas of white matter, irrespective of placement location.

Introduction

In the United States, traumatic brain injury (TBI) is the number one cause of neurological disability in young adults. Most cases are classified as mild TBI (mTBI), which can result in chronic post-concussive symptoms (PCS). Clinical management of mTBI patients, unfortunately is rarely based on biomarkers, due to the lack of findings on conventional imaging. Fortunately, quantitative MR techniques, such as diffusion tensor imaging (DTI) and proton MR spectroscopy (1H-MRS) have shown microstructural and biochemical changes in normal-appearing tissue, motivating research into their potential clinical use1,2. Since axonal injury is the primary TBI outcome, and has been extensively documented with DTI1,3 and 1H-MRS2, 4-7, our goal was to characterize its regional distribution in order to identify regions prone to disproportionate injury, hence, candidate targets for single-voxel or multi-voxel clinical 1H-MRS of mTBI. We utilized a dataset of PCS-positive patients in which we previously showed diffuse axonal abnormalities, i.e. lower global white matter (WM) N-acetyl-aspartate (NAA) levels compared to controls8.

Methods

Subjects: Fifteen PCS-positive mTBI patients (Table 1) and 12 age- and gender-matched controls. Data acquisition: T1-weighted MRI (MP-RAGE), T2-weighted MRI (FLAIR), B0 shimming, 10×8×4.5 cm (AP×LR×IS)=360 cm3 1H-MRS VOI (PRESS TE/TR=35/1800 ms), encoded to 480 voxels, each 1.0×1.0×0.75 cm3 (Fig. 1). Metabolite quantification: Absolute amounts of NAA, creatine (Cr), choline (Cho) and myo-inositol (mI) were obtained using phantom replacement with correction for T1 and T2 relaxation time differences between in vivo and in vitro. Segmentation: Six WM regions (body, genu, splenium of the corpus callosum, corona radiata, frontal and occipital WM) were manually outlined in 3D on each patient's axial MP-RAGE images based on DTI atlas parcellations9, as shown in Fig. 1 and 2. Global WM, gray matter (GM) and cerebro-spinal fluid (CSF) masks were obtained from the MP-RAGE using SPM. Regional 1H-MRS: All masks were co-registered with the 1H-MRS matrix, yielding their volume in every 1H-MRS voxel. This enabled CSF and GM partial volume control: only voxels with <30% of each were retained for subsequent analyses. Next, the goal was to ensure similar statistical precision for the analysis of each WM region, since larger regions (e.g. corona radiata) would normally contribute more voxels than smaller regions (e.g. genu), which would translate into better precision for the former because of voxel averaging. To avoid this scenario, we used similar number of voxels for each WM region by determining the optimal trade-off between mask inclusion and number of selected voxels. The resulting minimal voxel mask fractions used for each region were 40% for body, 50% for genu and splenium, 60% for occipital and 70% for corona radiata. Finally, only voxels with metabolite Cramer-Rao lower bounds<20% and 4<linewidths<13 Hz were included. Statistics: Unpaired student t tests with Bonferroni correction for multiple comparisons.

Results

The metabolic concentrations in each WM region are shown in Table 2, and their distributions are plotted in Fig. 3. There were no statistically significant differences in any metabolite between patients and controls, in any WM region, even before correction for multiple comparisons. However, as evident from Fig. 3, the median NAA concentration in each WM region was lower than controls’.

Discussion

The WM regions were selected on the basis of being the most commonly injured, based on previous 1H-MRS4-7, DTI3 and histopathology10-12. The additional criterion was that small tracts, unsuitable for the course spatial resolution of 1H-MRS were not considered. We ensured similar statistical precision among all comparisons, albeit at the cost of accuracy; however, this was an appropriate trade-off for this study, which had the goal of comparing the ability of 1H-MRS to detect injury amongst different regions. There were two main findings. First, while there were no significant differences, NAA in patients was lower across all WM regions. This indicated that metabolic axonal injury is truly diffuse, i.e. no region is spared, but also no region sustains injury of much larger proportion than others. Second, despite careful partial volume control, regional analysis of multi-voxel data lacked the sensitivity to detect (the clearly present) regional injury. This motivates the use of: (i) global WM multi-voxel approaches, which benefit from increased sensitivity (i.e. precision) due to voxel averaging13; or (ii) large volumes-of-interest (e.g. single-voxels) in pure WM, without consideration of locale.

Conclusion

Metabolic axonal injury in mTBI is diffusely distributed among commonly injured tracts, but multi-voxel 1H-MRS may lack sensitivity for its detection on a regional basis. These results motivate the use of 1H-MRS approaches with higher sensitivity, such as global WM averaging, or large single-voxels in areas of pure WM, irrespective of placement location.

Acknowledgements

This work was supported by NIH grants NS050520, NS29029, EB01015 and the Center for Advanced Imaging Innovation and Research (CAI2R, www.cai2r.net), a NIBIB Biomedical Technology Resource Center (NIH P41 EB017183). Assaf Tal acknowledges the support of the Monroy-Marks Career Development Fund, the Carolito Stiftung Fund, the Leona M. and Harry B. Helmsley Charitable Trust and the historic generosity of the Harold Perlman Family.

References

1. Shenton ME, Hamoda HM, Schneiderman JS, Bouix S, Pasternak O, Rathi Y, Vu MA, Purohit MP, Helmer K, Koerte I, Lin AP, Westin CF, Kikinis R, Kubicki M, Stern RA, Zafonte R. A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imaging Behav 2012;6:137-192.

2. Lin AP, Liao HJ, Merugumala SK, Prabhu SP, Meehan WP, 3rd, Ross BD. Metabolic imaging of mild traumatic brain injury. Brain Imaging Behav 2012;6:208-223.

3. Hulkower MB, Poliak DB, Rosenbaum SB, Zimmerman ME, Lipton ML. A decade of DTI in traumatic brain injury: 10 years and 100 articles later. AJNR Am J Neuroradiol 2013;34:2064-2074.

4. Gasparovic C, Yeo R, Mannell M, Ling J, Elgie R, Phillips J, Doezema D, Mayer A. Neurometabolite Concentrations in Gray and White Matter in Mild Traumatic Brain Injury: A 1HMagnetic Resonance Spectroscopy Study. J Neurotrauma 2009.

5. Holshouser BA, Tong KA, Ashwal S, Oyoyo U, Ghamsary M, Saunders D, Shutter L. Prospective longitudinal proton magnetic resonance spectroscopic imaging in adult traumatic brain injury. J Magn Reson Imaging 2006;24:33-40.

6. Aaen GS, Holshouser BA, Sheridan C, Colbert C, McKenney M, Kido D, Ashwal S. Magnetic resonance spectroscopy predicts outcomes for children with nonaccidental trauma. Pediatrics 2010;125:295-303.

7. Johnson B, Gay M, Zhang K, Neuberger T, Horovitz SG, Hallett M, Sebastianelli W, Slobounov S. The use of magnetic resonance spectroscopy in the subacute evaluation of athletes recovering from single and multiple mild traumatic brain injury. J Neurotrauma 2012;29:2297-2304.

8. Kirov, I.I., Tal, A., Babb, J.S., Reaume, J., Bushnik, T., Ashman, T.A., Flanagan, S., Grossman, R.I., Gonen, O., 2013. Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury. J. Neurotrauma 30, 1200–1204.

9. Mori, S., Wakana, S., Nagae-Poetscher, L., van Zijl, P., 2005. MRI Atlas of Human White Matter. 1st ed. Elsevier, Amsterdam.

10. Browne KD, Chen XH, Meaney DF, Smith DH. Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 2011;28:1747-1755.

11. Cecil KM, Lenkinski RE, Meaney DF, McIntosh TK, Smith DH. High-field proton magnetic resonance spectroscopy of a swine model for axonal injury. J Neurochem 1998;70:2038-2044.

12. Mouzon B, Chaytow H, Crynen G, Bachmeier C, Stewart J, Mullan M, Stewart W, Crawford F. Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. J Neurotrauma 2012;29:2761-2773.

13. Tal A, Kirov II, Grossman RI, Gonen O. The role of gray and white matter segmentation in quantitative proton MR spectroscopic imaging. NMR Biomed 2012;25:1392-1400.

Figures

Table 1: Patient demographic and clinical data

1Days, GCS = Glasgow Coma Scale


Figure 1: 1H-MRSI positioning and example spectra

T1-weighted MRI (a, b, c) of a patient, superimposed with the 1H-MRSI volume-of-interest and the outlined: body of corpus callosum (e), and bilateral corona radiata (d). The spectra from these regions are outlined within the axial spectral matrix and magnified below.


Figure 2: White matter region segmentation and voxel selection

Left: The outlined genu (a), splenium (b), frontal (c) and occipital (d) WM, and their selected voxels after thresholding mask content, and CSF/GM partial volume.

Right: The segmented genu with its selected voxels indicated. Their corresponding spectra are shown below.


Table 2: Average metabolite concentrations of all metabolites (in millimolar, mM) within all white matter regions in patients and controls

Figure 3: Metabolite distributions of NAA within all white matter regions in patients (gray) and controls (white)



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0860